Skip to main content
. 2023 Oct 10;28(6):226. doi: 10.3892/mmr.2023.13113

Table VII.

Association between genotypic frequencies of FGFR2 variants and immunohistochemical subtyping of patients with breast cancer

Allele A-like, n (freq.) B-like, n (freq.) B/HER2-like, n (freq.) HER2-like, n (freq.) TNBC, n (freq.) P-value
rs2981582 108 439 208 58 139 0.525a
  GG 36 (0.333) 133 (0.303) 54 (0.260) 16 (0.276) 37 (0.266)
  GA 42 (0.389) 209 (0.476) 105 (0.505) 24 (0.414) 66 (0.475)
  AA 30 (0.278) 97 (0.221) 49 (0.236) 18 (0.310) 36 (0.259)
rs35054928 108 442 210 57 140 0.833a
  CC/CC 39 (0.361) 152 (0.344) 69 (0.329) 23 (0.404) 46 (0.329)
  CC/C- 47 (0.435) 207 (0.468) 105 (0.500) 21 (0.368) 70 (0.500)
  C-/C- 22 (0.204) 83 (0.188) 36 (0.171) 13 (0.228) 24 (0.171)
rs2981578 108 442 209 58 140 0.177b
  CC 92 (0.852) 391 (0.885) 192 (0.919) 50 (0.862) 117 (0.836)
  CT 15 (0.139) 50 (0.113) 16 (0.077) 8 (0.138) 23 (0.164)
  TT 1 (0.009) 1 (0.002) 1 (0.005) 0 0
rs11200014 108 442 210 57 139 0.139a
  GG 76 (0.704) 330 (0.747) 163 (0.776) 37 (0.649) 108 (0.777)
  GA 31 (0.287) 104 (0.235) 39 (0.186) 18 (0.316) 30 (0.216)
  AA 1 (0.009) 8 (0.018) 8 (0.038) 2 (0.035) 1 (0.007)
a

Pearson χ2,

b

Fisher's exact test. A-like, Luminal-A; B-like, Luminal B/HER2-; B/HER2-like, Luminal B/HER2+; TNBC, triple-negative breast cancer.